Who We Are
Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases.
Around the world, our medicines help millions of people in their fight against such diseases as cancer, cardiovascular disease, hepatitis B and hepatitis C, HIV/AIDS and rheumatoid arthritis.
Bristol-Myers Squibb is also leading advances in the rapidly evolving field of cancer research and treatment known as immuno-oncology, an innovative area of research that seeks to help the body’s own immune system to fight cancer. The goal of immuno-oncology is to change survival expectations and the way patients live with cancer.
At Bristol-Myers Squibb, our strategy combines the reach and resources of a major pharma company with the entrepreneurial spirit and agility of a successful biotech company.
Innovation is critical for successfully executing our strategy. That innovation is enhanced by a diverse workforce and an inclusive culture. In Canada, the work of our employees - over 300 across the country - is bound together by one thing: the desire to help patients prevail over serious diseases.
And at the end of the day, our success as a next-generation BioPharma leader is measured by exactly that – the difference we make in the lives of patients.